序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
41 공역화 리놀렌산을 생산하는 신규한 균주, 이를 함유하는 캡슐제 및 이를 이용한 기능성 식품 KR1020050004128 2005-01-17 KR1020050023364A 2005-03-09 김소미; 오덕근; 백대헌; 신홍식; 박시호; 이유진; 엄수종; 노영쇠; 박종섭
PURPOSE: Provided are a conjugated linoleic acid(CLA) producing microorganism, a capsulated composition comprising the same microorganism, and the functional food using the same composition, which microorganism has improved conjugated linoleic acid(CLA) producing activity, secretes CLA into the medium and accumulates CLA within the biomass, and has tolerance against acids such as acid in the stomach and bile juice and antibiotics. CONSTITUTION: The CLA producing microorganism which converts linoleic acid(LA) into conjugated linoleic acid(CLA) is provided, wherein the CLA producing microorganism is Enterococcus faecium CBG-C5(KACC 91002). The capsulated composition for prevention and treatment of cancer, arteriosclerosis, diabetes and obeseness comprises the CLA producing microorganism Enterococcus faecium CBG-C5(KACC 91002), wherein the coating material is water-soluble polysaccharides. The functional food containing the capsulated composition is provided, wherein the food is yoghurt, cheese, kimchi and jang(fermented soybean).
42 Method for stimulating intestinal barrier integrity after non-natural birth EP11178047.4 2006-10-06 EP2407036B1 2015-11-04 Schmitt, Joachim; Boehm, Günther; Beermann, Christopher
The present invention relates to methods for feeding and to compositions to be adminis
43 PET FOOD COMPOSITION FOR SKIN PHOTOPROTECTION EP03742552.7 2003-02-18 EP1478242B1 2014-04-30 BRETON, Lionel; BUREAU-FRANZ, Isabelle
44 Method for stimulating intestinal barrier integrity after birth by caesarean section EP09161674.8 2006-10-06 EP2105055B1 2014-01-22 Schmitt, Joachim; Boehm, Günther; Beermann, Christopher
The present invention relates to methods for feeding and to compositions to be adminis
45 Method for stimulating the intestinal flora EP13171226.7 2006-10-20 EP2638812A1 2013-09-18 Boehm, Günther; Knol, Jan; Stahl, Bernd

The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.

46 Method for stimulating the intestinal flora in infants delivered by caesarean section EP09011197.2 2006-10-20 EP2140771A1 2010-01-06 Boehm, Günther; Stahl, Bernd; Knol, Jan

The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.

47 METHOD FOR STIMULATING THE INTESTINAL FLORA EP06806443.5 2006-10-20 EP1940250B1 2009-09-16 BOEHM, Günther; STAHL, Bernd; KNOL, Jan
The present invention relates to methods for feeding and to compositions to be adminis
48 PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION EP06799537.3 2006-10-06 EP1940246A1 2008-07-09 SCHMITT, Joachim; STAHL, Bernd; KNOL, Jan
The present invention relates to methods for feeding and to compositions to be adminis
49 FERMENTED FOODS CONTAINING BIFIDOBACTERIUM EP00963042 2000-10-02 EP1224867A4 2005-01-19 MATSUKI TAKAHIRO; SONOIKE KOICHIRO; YASUDA EMI; IINO TOHRU; ISHIKAWA FUMIYASU; TOCHIYA KAORU
Fermented foods having a sufficient stability and an excellent flavor as foods to be taken orally are produced by using a bifidobacterium belonging to Bifidobacterium catenulatum or Bifidobacterium pseudocatenulatum which has never been employed in foods so far. These fermented foods containing a bifidobacterium are obtained by fermenting a medium containing soybean milk as the main component by using a bifidobacterium selected from Bifidobacterium catenulatum and Bifidobacterium pseudocatenulatum.
50 비피도박테리움 CECT 7765 및 과체중, 비만 및 관련 병리의 예방 및/또는 치료에서의 그의 이용 KR1020137017724 2011-12-07 KR1020140147656A 2014-12-30 산쯔헤르란즈,요란다; 아르레떼산타크루즈,요란다; 가우핀,파올라
본 발명은 비피도박테리움 CECT 7765 균주; 그의 세포 성분, 대사산물, 및 분비된 분자; 다른 미생물과 그의 조합물; 및 상기 생산물들을 포함하는 조성물들에 관한 것이며, 또한 비만, 과체중, 고혈당증 및 당뇨병, 바람직하게는 제 2형 진성 당뇨병, 간 지방증 또는 지방간, 이상지질혈증, 대사성 증후군, 비만 및 과체중관련 면역계 기능이상; 및 비만 및 과체중 관련 장 미생물군의 불균형화된 조성의 예방 및/또는 치료를 위한 비피도박테리움 슈도카테눌라텀 종의 균주의 이용, 또는 CECT 7765 균주의 이용에 관한 것이다.
51 공액 지방산의 제조방법 및 그 방법에 의해 얻어진 음식품 KR1020047016341 2003-04-11 KR100928890B1 2009-11-30 미즈사와나오미; 사카이마사시; 쿠도사토시; 시라사와유키오
이중결합을 적어도 2개이상 갖는 불포화 지방산을, 공액화 처리능을 갖는 Lactobacillus oris, Lactobacillus pontis, Lactobacillus panis, Bifidobacterium breve, Bifidobacterium bifidum, Bifidobacterium infantis , 또는 Bifidobacterium pseudocatenulatum 의 세균군으로부터 선택되는 1종이상의 세균의 생균, 사균체, 균체 추출액 또는 그 세균으로부터 얻은 효소를 이용하여 공액화하고, 생리활성이 높다고 되어 있는 cis-9, trans-11형 공액 리놀산으로 대표되는 공액 지방산을 선택적이고 또한 고효율로 제조한다.
52 공역화 리놀렌산을 생산하는 신규한 균주, 이를 함유하는 캡슐제 및 이를 이용한 기능성 식품 KR1020030023164 2003-04-12 KR1020030081180A 2003-10-17 김소미; 오덕근; 백대헌; 신홍식; 박시호; 이유진; 엄수종; 노영쇠; 박종섭
PURPOSE: A novel microorganism capable of producing conjugated linoleic acid, a capsulated composition comprising the same, and a preparation method thereof are provided. The microorganism has high conjugated linoleic acid production yield and gastric juice and bile acid tolerance. CONSTITUTION: A microorganism capable of producing conjugated linoleic acid is provided, wherein the microorganism is Bifidobacterium breve CBG-C2 KACC 91001 and KCTC 10462BP, Bifidobacterium pseudocartenulatum CBG-C4 KACC 91003, and Enterococcus faecium CBG-C5 KACC 91002 and KCTC 10208BP. The capsulated composition for prevention and treatment of diseases capable of being inhibited by the conjugated linoleic acid, such as cancer, sclerosis of the arteries, diabetes and corpulence comprises the microorganism capable of producing conjugated linoleic acid.
53 COMPOSITION FOR USE IN STIMULATING THE INTESTINAL FLORA IN INFANTS DELIVERED BY CAESAREAN SECTION EP17205437.1 2006-10-20 EP3326634A3 2018-07-18 Boehm, Günther; Knol, Jan; Stahl, Bernd

The present invention relates to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two, preferably three, different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants.

54 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH EP15181073.6 2006-10-06 EP2984943A1 2016-02-17 Schmitt, Joachim; Boehm, Günther; Beermann, Christopher

The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides.

55 BIFIDOBACTERIUM CECT 7765 AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF EXCESS WEIGHT, OBESITY AND RELATED PATHOLOGIES EP11846843 2011-12-07 EP2650002A4 2014-08-13 SANZ HERRANZ YOLANDA; ARLETTE SANTACRUZ YOLANDA; GAUFFIN PAOLA
The present invention relates to the Bifidobacterium CECT 7765 strain, to its cell components, metabolites, and secreted molecules, to the combinations thereof with other microorganisms, and to compositions comprising the aforementioned products, as well as to the use of a strain of the Bifidobacterium pseudocatenulatum species, or to using the CECT 7765 strain for the prevention and/or treatment of obesity, overweight, hyperglycemia and diabetes, preferably type 2 diabetes mellitus, hepatic steatosis or fatty liver, dyslipidemia, metabolic syndrome, immune system dysfunction associated with obesity and overweight; and an unbalanced composition of the intestinal microbiota associated with obesity and overweight.
56 Method for stimulating the intestinal flora in infants delivered by caesarean section EP09011197.2 2006-10-20 EP2140771B1 2013-12-11 Boehm, Günther; Stahl, Bernd; Knol, Jan
The present invention relates to methods for feeding and to compositions to be adminis
57 Method for stimulating intestinal barrier integrity after non-natural birth EP11178047.4 2006-10-06 EP2407036A1 2012-01-18 Schmitt, Joachim; Boehm, Günther; Beermann, Christopher

The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides

58 PROCESS FOR PRODUCING CONJUGATED FATTY ACID AND FOOD/DRINK OBTAINED BY THE PROCESS EP03746461.7 2003-04-11 EP1500706B1 2009-10-14 MIZUSAWA, Naomi Kabushiki Kaisha Yakult Honsha; SAKAI, Masashi Kabushiki Kaisha Yakult Honsha; KUDO, Satoshi Kabushiki Kaisha Yakult Honsha; SHIRASAWA, Yukio Kabushiki Kaisha Yakult Honsha
A conjugated fatty acid typified by cis-9, trans-11 conjugated linoleic acid seemingly having a high physiological activity is selectively and highly efficiently produced by conjugating an unsaturated fatty acid having at least two double bonds with the use of viable cells, dead cells or a cell extract of one or more bacteria having a conjugation ability selected from the group consisting of Lactobacillus oris, Lactobacillus pontis, Lactobacillus panis, Bifidobacterium breve, Bifidobacterium bifidium, Bifidobacterium infantis and Bifidobacterium pseudocatenulatum or an enzyme obtained therefrom.
59 Method for stimulating intestinal barrier integrity after birth by caesarean section EP09161674.8 2006-10-06 EP2105055A1 2009-09-30 Schmitt, Joachim; Boehm, Günther; Beermann, Christopher

The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides

60 METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH EP06799538.1 2006-10-06 EP1940247B1 2009-06-03 SCHMITT, Joachim; BOEHM, Gunther; BEERMANN, Christopher
The present invention relates to methods for feeding and to compositions to be adminis
QQ群二维码
意见反馈